Coletiva de imprensa: anúncios sobre a vacina do Butantan - 23/12/2020
Date:
23/12/2020
O Instituto Butantan e o Governo de São Paulo informam que a vacina contra o coronavírus, desenvolvida em parceria com a biofarmacêutica Sinovac Life Science, atingiu índice de eficácia superior ao mínimo recomendado pela OMS (Organização Mundial de Saúde) e, assim, poderá ter seu registro aprovado para imunizar a população.
As medidas adotadas pelo Governo de SP para o combate ao coro...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Quarantine/organization & administration, Epidemiological Monitoring, Governmental Research Institutes, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Clinical Trial, Phase III, Brazilian Health Surveillance Agency, Healthy Volunteers, Vaccine Potency, Gorinchteyn, Jean , Plano São Paulo, COVID-19, Coronavac, Instituto Butantan, Sinovac Biotech
Qual a importância do fim do estudo para emissão do registro?
Date:
15/12/2020
Saiba mais em www.saopaulo.sp.gov.br/coronavirus/vacina
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/immunology, Brazilian Health Surveillance Agency, Clinical Trial, Phase III, Healthy Volunteers, COVID-19, Plano São Paulo, Coronavac, Instituto Butantan, Sinovac Biotech
Coletiva de imprensa: anúncios do Governo SP - 14/12/2020
Date:
14/12/2020
O Governador João Doria confirmou nesta segunda-feira (14) que o estudo clínico conclusivo da vacina do Instituto Butantan contra o coronavírus será divulgado no dia 23 de dezembro. A medida dá mais agilidade aos trâmites de certificação na Anvisa (Agência Nacional de Vigilância Sanitária) e demais órgãos internacionais de saúde.
“Os brasileiros querem agilidade, querem as vacinas ...
See more details
Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Betacoronavirus/immunology, Epidemiological Monitoring, Immunization Programs/organization & administration, Brazilian Health Surveillance Agency, Clinical Trial, Phase III, Viral Vaccines/supply & distribution, Viral Vaccines/immunology, Healthy Volunteers, Governmental Research Institutes, Risk Groups, Police/organization & administration, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Pandemics/statistics & numerical data, Social Isolation, Masks, COVID-19, Plano São Paulo, Coronavac, Instituto Butantan, Sinovac Biotech
I Seminário Nacional do Conass e Conasems - 09/12/2020
Date:
09/12/2020
As inscrições para o I Seminário Conass e Conasems encerram amanhã (terça-feira, 08), às 18h.
O impacto da pandemia de Covid-19 nos serviços de saúde e a resposta do SUS serão os principais temas abordados no I Seminário Nacional do Conass e Conasems. O evento, que será realizado de forma virtual, ocorrerá entre os dias 9 e 11 de dezembro, sempre entre 14h30 e 18h.
As experiências be...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Chronic Disease/prevention & control, Betacoronavirus/immunology, Pneumonia, Viral/prevention & control, Coronavirus Infections/prevention & control, Viral Vaccines/supply & distribution, Health Councils/organization & administration, Unified Health System/organization & administration, Congress, Brazil/epidemiology, Public Health Systems, Elective Surgical Procedures, Social Isolation, Masks, Financial Resources in Health/economics, Primary Health Care/organization & administration, Personal Protective Equipment/supply & distribution, Noncommunicable Diseases/prevention & control, Health Personnel/organization & administration, Hospital Administration, Equity in Access to Health Services, Telemedicine, Health Management, Pandemics/statistics & numerical data, Polymerase Chain Reaction/statistics & numerical data, Coronavirus Infections/diagnosis, Pneumonia, Viral/diagnosis, Governmental Research Institutes, Clinical Trial, Phase III, Healthy Volunteers, Brazilian Health Surveillance Agency, Immunization Programs/organization & administration, Vaccine Potency, COVID-19, Pazuello, Eduardo , Coronavac, Instituto Butantan, Sinovac Biotech, Pfizer, Astrazeneca, Fiocruz, Vacina de Oxford
Coletiva de imprensa: avanços importantes nos testes clínicos da fase 3 da Coronavac
Date:
23/11/2020
O Governo de São Paulo e o Instituto Butantan confirmaram nesta segunda-feira (23) que o estudo clínico da CoronaVac chegou à fase final e os resultados sairão já na primeira semana de dezembro. A previsão é que 46 milhões de doses estejam disponíveis no Brasil até janeiro de 2021.
Isso será possível porque o estudo clínico alcançou o patamar necessário para abertura da pesquisa e a...
See more details
Pneumonia, Viral/prevention & control, Coronavirus Infections/prevention & control, Pandemics/prevention & control, Betacoronavirus/immunology, Viral Vaccines/immunology, Governmental Research Institutes, Clinical Trial, Phase III, Healthy Volunteers, Epidemiological Monitoring, Hospital Bed Capacity/statistics & numerical data, Local Health Systems/organization & administration, Brazilian Health Surveillance Agency, Mass Vaccination, Intensive Care Units/statistics & numerical data, Coronavirus Infections/diagnosis, Pneumonia, Viral/diagnosis, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech, Gorinchteyn, Jean
Coletiva de imprensa: anúncios do Governo SP - 12/11/2020
Date:
12/11/2020
O Governador João Doria anunciou nesta quinta-feira (12) a assinatura de contrato para revitalização da antiga Usina da Traição, firmado entre a Empresa Metropolitana de Águas e Energia S.A. (EMAE) e o consórcio Usina São Paulo SPE S.A.
O grupo venceu a licitação realizada em setembro e será responsável por implementar espaços de uso público na área de 29.804 metros quadrados, inclu...
See more details
Betacoronavirus/immunology, Coronavirus Infections/epidemiology, Coronavirus Infections/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/epidemiology, Pneumonia, Viral/immunology, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Epidemiological Monitoring, Local Health Systems/organization & administration, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Brazilian Health Surveillance Agency, Viral Vaccines/supply & distribution, Viral Vaccines/immunology, Clinical Trial, Phase III, Environment, Environmental Restoration and Remediation, Healthy Volunteers, COVID-19, Plano São Paulo, Doria, João, Coronavac, Instituto Butantan, Sinovac Biotech, Novo Rio Pinheiros , Empresa Metropolitana de Águas e Energia S.A., Usina São Paulo SPE S.A
O evento adverso com o voluntário tem relação com a vacina?
Date:
10/11/2020
Saiba mais em: https://www.saopaulo.sp.gov.br/corona...
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Viral Vaccines/adverse effects, Healthy Volunteers, Brazilian Health Surveillance Agency, Clinical Trial, Phase III, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech
A Anvisa foi notificada sobre o evento adverso grave?
Date:
11/11/2020
Saiba mais em: https://www.saopaulo.sp.gov.br/corona...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Healthy Volunteers, Clinical Trial, Phase III, Brazilian Health Surveillance Agency, Viral Vaccines/immunology, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech
Como é o formulário de notificação recebido pela Anvisa?
Date:
11/11/2020
Saiba mais em: https://www.saopaulo.sp.gov.br/corona...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/adverse effects, Healthy Volunteers, Brazilian Health Surveillance Agency, Clinical Trial, Phase III, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech
Coletiva de imprensa: informações sobre a Coronavac
Date:
10/11/2020
Saiba mais em: https://www.saopaulo.sp.gov.br/corona...
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Viral Vaccines/immunology, Governmental Research Institutes, Healthy Volunteers, Brazilian Health Surveillance Agency, Viral Vaccines/adverse effects, Clinical Trial, Phase III, COVID-19, Plano São Paulo, Coronavac, Instituto Butantan, Sinovac Biotech
